Molecular basis for cA6 synthesis by a type III-A CRISPR–Cas enzyme and its conversion to cA4 production
Nucleic Acids Research · 2024
DOI: 10.1093/nar/gkae603 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2024. Verfasst von Hemant N Goswami und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Molecular Biophysics, Florida State University, Tallahassee, FL 32306, USA. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, CRISPR-Associated Proteins. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCRR NIH HHS, NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
The type III-A (Csm) CRISPR–Cas systems are multi-subunit and multipronged prokaryotic enzymes in guarding the hosts against viral invaders. Beyond cleaving activator RNA transcripts, Csm confers two additional activities: shredding single-stranded DNA and synthesizing cyclic oligoadenylates (cOAs) by the Cas10 subunit. Known Cas10 enzymes exhibit a fascinating diversity in cOA production. Three major forms—cA3, cA4 and cA6have been identified, each with the potential to trigger unique downstream effects. Whereas the mechanism for cOA-dependent activation is well characterized, the molecular basis for synthesizing different cOA isoforms remains unclear. Here, we present structural characterization of a cA6-producing Csm complex during its activation by an activator RNA. Analysis of the captured intermediates of cA6 synthesis suggests a 3′-to-5′ nucleotidyl transferring process. Three primary adenine binding sites can be identified along the chain elongation path, including a unique tyrosine–threonine dyad found only in the cA6-producing Cas10. Consistently, disrupting the tyrosine–threonine dyad specifically impaired cA6 production while promoting cA4 production. These findings suggest that Cas10 utilizes a unique enzymatic mechanism for forming the phosphodiester bond and has evolved distinct strategies to regulate the cOA chain length.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Molecular Biophysics, Florida State University, Tallahassee, FL 32306, USA.
- Department of Chemistry and Biochemistry, Florida State University, Tallahassee, FL 32306, USA.
- Department of Biological Sciences, Florida State University, Tallahassee, FL 32306, USA.
- Biochemistry and Molecular Biology, Genetics and Microbiology, University of Georgia, Athens, GA 30602, USA.
ORCID-Profile: Hemant N Goswami, Michael P Terns, Hong Li
Förderung
- NCRR NIH HHS
- NIH HHS
- NIGMS NIH HHS
- National Institutes of Health
Zitieren
APA
Goswami, H. N., Ahmadizadeh, F., Wang, B., Addo-Yobo, D., Zhao, Y., Whittington, A. C., He, H., Terns, M. P., & Li, H. (2024). Molecular basis for cA6 synthesis by a type III-A CRISPR–Cas enzyme and its conversion to cA4 production. Nucleic Acids Research. https://doi.org/10.1093/nar/gkae603
Vancouver
Goswami HN, Ahmadizadeh F, Wang B, Addo-Yobo D, Zhao Y, Whittington AC, et al. Molecular basis for cA6 synthesis by a type III-A CRISPR–Cas enzyme and its conversion to cA4 production. Nucleic Acids Research. 2024. doi:10.1093/nar/gkae603
BibTeX
@article{Goswami2024,
author = {Goswami, Hemant N and Ahmadizadeh, Fozieh and Wang, Bing and Addo-Yobo, Doreen and Zhao, Yu and Whittington, A Carl and He, Huan and Terns, Michael P and Li, Hong},
title = {Molecular basis for cA6 synthesis by a type III-A CRISPR–Cas enzyme and its conversion to cA4 production},
journal = {Nucleic Acids Research},
year = {2024},
doi = {10.1093/nar/gkae603}
}
EUVIMED